| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,573,000 | 15,213,000 | 13,286,000 | 13,973,000 | | Cost of Revenue | (14,448,000) | 11,264,000 | 9,660,000 | 10,346,000 | | | Gross Profit | 4,267,000 | 3,949,000 | 3,626,000 | 3,627,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,152,000 | 1,498,000 | 1,290,000 | 1,677,000 | | Non Recurring | 1,000 | 1,000 | 1,000 |
-
| | Others | 18,000 | 21,000 | 15,000 | 15,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,850,000 | 2,429,000 | 2,320,000 | 1,935,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 217,000 | | Earnings Before Interest And Taxes | 2,278,000 | 2,429,000 | 2,320,000 | 2,152,000 | | Interest Expense | (351,000) | 193,000 | 158,000 | 323,000 | | Income Before Tax | 2,629,000 | 2,236,000 | 2,162,000 | 1,829,000 | | Income Tax Expense | 775,000 | 639,000 | 645,000 | 519,000 | | Minority Interest |
-
| 41,000 | (41,000) | (59,000) | | | | Net Income From Continuing Ops | 1,706,000 | 1,638,000 | 1,476,000 | 1,251,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,706,000 | 1,638,000 | 1,476,000 | 1,251,000 | | Preferred Stock And Other Adjustments | 92,000 | (92,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $1,798,000 | $1,546,000 | $1,476,000 | $1,251,000 |
|
0.12% Nasdaq 
0.84 (1.70%) 
Income Statement
